Wanbury Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Wanbury Share Price

174.2113.93 (8.69%)

Live
As On: 04 Mar, 2025, 11:33 AM IST
As On: 04 Mar, 2025, 11:33 AM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Open	160.30
High	179.95
Low	156.79
Prev Close	160.29
Volume	1,48,642
VWAP(₹)	171.84

Wanbury Ltd share price insights

ROE Outperforming 5 Year Average
Company delivered ROE of 200.26% in year ending Mar 31, 2024 outperforming its 5 year avg. of -54.54%. (Source: Consolidated Financials)
Quarterly Topline Performance
Company witnessed QoQ revenue decline of 17.52%, which is lowest in the last 3 years. (Source: Consolidated Financials)
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 97.52% as compared to Nifty Smallcap 100 which gave a return of 48.06%. (as of last trading session)
Employee & Interest Expense
Company has spent 5.07% of its operating revenues towards interest expenses and 15.1% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Wanbury Ltd Share Price Update
Wanbury Ltd. share price moved up by 8.69% from its previous close of Rs 160.29. Wanbury Ltd. stock last traded price is 174.21
Share Price Value
Today/Current/Last 174.21173.55
Previous Day 160.29162.25

Found Insights useful?

Wanbury Ltd Share Price Returns

1 Day	8.69%
1 Month	-19.32%
3 Months	-34.51%
1 Year	6.88%
3 Years	114.68%
5 Years	587.22%

Key Metrics

PE Ratio(x)	12.95
EPS - TTM(₹)	13.40
MCap(₹ Cr.)	580.99
MCap Rank	82
PB Ratio(x)	18.79
Div Yield(%)	-
Face Value(₹)	10.00
52W High(₹)	323.53
52W Low(₹)	123.00
MCap/Sales	0.83
Beta(1 Month)	0.60
BV/Share(₹)	8.53

Wanbury Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Wanbury News & Analysis

View all Wanbury Share News & Announcements

Wanbury Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Wanbury Financials

	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Total Income	134.29	162.82	132.05	140.33	146.19
Total Income Growth (%)	-17.52	23.30	-5.90	-4.01	0.67
Total Expenses	122.83	144.51	123.42	98.97	127.67
Total Expenses Growth (%)	-15.00	17.08	24.71	-22.49	-2.06
EBIT	11.46	18.32	8.63	41.37	18.52
EBIT Growth (%)	-37.44	112.24	-79.14	123.41	24.63
Profit after Tax (PAT)	1.22	8.02	1.04	33.63	10.27
PAT Growth (%)	-84.81	672.95	-96.92	227.40	39.54
EBIT Margin (%)	8.53	11.25	6.54	29.48	12.67
Net Profit Margin (%)	0.91	4.92	0.79	23.97	7.03
Basic EPS (₹)	0.38	2.44	0.32	10.28	3.13

	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Total Income	134.29	162.82	132.05	140.33	146.19
Total Income Growth (%)	-17.52	23.30	-5.90	-4.01	0.67
Total Expenses	122.83	144.51	123.42	124.52	127.67
Total Expenses Growth (%)	-15.00	17.08	-0.88	-2.47	-2.06
EBIT	11.46	18.32	8.63	15.81	18.52
EBIT Growth (%)	-37.44	112.24	-45.41	-14.62	24.63
Profit after Tax (PAT)	1.22	8.02	1.04	8.08	10.27
PAT Growth (%)	-84.81	672.94	-87.16	-21.38	39.54
EBIT Margin (%)	8.53	11.25	6.54	11.27	12.67
Net Profit Margin (%)	0.91	4.92	0.79	5.76	7.03
Basic EPS (₹)	0.38	2.44	0.32	2.47	3.14

	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	578.64	500.56	512.69	394.92	368.59
Total Revenue Growth (%)	15.60	-2.37	29.82	7.14	-8.01
Total Expenses	547.86	510.25	507.93	407.33	386.56
Total Expenses Growth (%)	7.37	0.46	24.70	5.37	-9.19
Profit after Tax (PAT)	55.96	-10.40	81.47	-12.61	64.46
PAT Growth (%)	-	-112.76	-	-119.56	-
Operating Profit Margin (%)	10.41	2.34	4.96	2.71	4.05
Net Profit Margin (%)	9.72	-2.08	15.93	-3.21	17.54
Basic EPS (₹)	17.10	-3.18	25.29	-5.04	26.90

	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	578.64	500.56	512.69	394.92	368.59
Total Revenue Growth (%)	15.60	-2.37	29.82	7.14	-8.01
Total Expenses	547.86	510.25	507.93	407.33	386.56
Total Expenses Growth (%)	7.37	0.46	24.70	5.37	-9.19
Profit after Tax (PAT)	30.40	-10.40	81.47	-12.61	64.46
PAT Growth (%)	-	-112.76	-	-119.56	-
Operating Profit Margin (%)	10.41	2.34	4.96	2.71	4.05
Net Profit Margin (%)	5.28	-2.08	15.93	-3.21	17.54
Basic EPS (₹)	9.29	-3.18	25.29	-5.04	26.90

All figures in Rs Cr, unless mentioned otherwise

Insights

Quarterly Topline Performance
Company witnessed QoQ revenue decline of 17.52%, which is lowest in the last 3 years. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 5.07% of its operating revenues towards interest expenses and 15.1% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	343.49	303.87	352.55	289.18	278.69
Total Assets Growth (%)	13.04	-13.81	21.91	3.76	-2.57
Total Liabilities	315.55	336.69	375.97	445.42	422.15
Total Liabilities Growth (%)	-6.28	-10.45	-15.59	5.51	-14.77
Total Equity	27.94	-32.82	-23.42	-156.24	-143.45
Total Equity Growth (%)	-	-	-	-	-
Current Ratio (x)	0.74	0.39	0.48	0.28	0.30
Total Debt to Equity (x)	3.94	-1.95	-2.86	-0.57	-0.87
Contingent Liabilities	70.29	1,033.26	908.54	889.88	1,012.55

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	343.49	302.25	351.00	287.60	277.16
Total Assets Growth (%)	13.64	-13.89	22.04	3.77	-2.62
Total Liabilities	315.55	309.50	348.81	418.26	395.00
Total Liabilities Growth (%)	1.95	-11.27	-16.60	5.89	-15.63
Total Equity	27.94	-7.26	2.19	-130.66	-117.83
Total Equity Growth (%)	-	-431.51	-	-	-
Current Ratio (x)	0.74	0.42	0.52	0.30	0.32
Total Debt to Equity (x)	3.94	-8.84	30.64	-0.68	-1.06
Contingent Liabilities	70.29	945.26	908.54	862.78	1,009.04

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	3.98	19.80	40.52	16.68	44.13
Net Cash used in Investing Activities	-16.63	-8.84	0.59	8.04	63.66
Net Cash flow from Financing Activities	14.55	-31.99	-28.58	-17.39	-107.87
Net Cash Flow	1.91	-21.03	12.53	7.34	-0.08
Closing Cash & Cash Equivalent	3.40	1.49	22.53	10.00	2.66
Closing Cash & Cash Equivalent Growth (%)	127.54	-93.37	125.23	275.84	-2.88
Total Debt/ CFO (x)	27.64	3.24	1.65	5.30	2.82

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	4.02	19.80	40.52	16.68	44.13
Net Cash used in Investing Activities	-16.63	-8.84	0.59	8.04	63.66
Net Cash flow from Financing Activities	14.55	-31.99	-28.58	-17.39	-107.87
Net Cash Flow	1.94	-21.03	12.53	7.34	-0.09
Closing Cash & Cash Equivalent	3.40	1.46	22.49	9.96	2.62
Closing Cash & Cash Equivalent Growth (%)	133.59	-93.53	125.72	279.91	-3.16
Total Debt/ CFO (x)	27.37	3.24	1.65	5.30	2.82

All figures in Rs Cr, unless mentioned otherwise

Insights

Increase in Cash from Investing
Company has used Rs 16.63 cr for investing activities which is an YoY increase of 88.12%. (Source: Consolidated Financials)

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	200.26	0.00	-347.88	0.00	-44.93
Return on Capital Employed (%)	46.34	-70.89	-351.22	-16.12	-46.06
Return on Assets (%)	16.29	-3.42	23.10	-4.35	23.13
Interest Coverage Ratio (x)	2.50	1.13	1.79	0.89	0.75
Asset Turnover Ratio (x)	1.78	1.52	1.60	1.39	1.30
Price to Earnings (x)	8.54	-11.75	3.41	-16.47	0.71
Price to Book (x)	17.09	-3.72	-11.86	-1.33	-0.32
EV/EBITDA (x)	7.97	7.57	8.67	13.92	6.23
EBITDA Margin (%)	12.67	4.82	7.20	5.20	6.69

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	108.79	0.00	3,724.18	0.00	-54.70
Return on Capital Employed (%)	46.34	129.25	138.00	-26.28	-221.47
Return on Assets (%)	8.85	-3.43	23.21	-4.38	23.25
Interest Coverage Ratio (x)	2.50	1.13	1.79	0.89	0.75
Asset Turnover Ratio (x)	1.78	1.53	1.60	1.39	1.31
Price to Earnings (x)	15.72	-11.75	3.41	-16.47	0.71
Price to Book (x)	17.09	-16.82	127.06	-1.59	-0.39
EV/EBITDA (x)	7.97	7.57	8.67	13.92	6.24
EBITDA Margin (%)	12.67	4.82	7.20	5.20	6.69

Insights

ROE Outperforming 5 Year Average
Company delivered ROE of 200.26% in year ending Mar 31, 2024 outperforming its 5 year avg. of -54.54%. (Source: Consolidated Financials)

Found Financials useful?

Wanbury Technicals

Buy/Sell Signals
No Data Available
Price Analysis
No Data Available
Pivot Levels
R1 - Pivot
-
S1 -
R2 - S2 -
R3 - S3 -
Average True Range
5 Days 14 Days 28 Days
- - -

Wanbury Ltd Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Wanbury Ltd	12.95	20.34	200.26	46.34	16.29	13.43	10.41	9.72	17.10	0.74	3.94	27.64
Kopran Ltd	17.23	1.67	10.37	14.51	6.85	7.19	12.38	8.29	10.57	2.08	0.20	2.29
Anuh Pharma	15.45	2.67	20.62	26.84	13.47	14.05	12.15	9.28	11.98	2.20	0.01	0.16
Medicamen Bio	80.58	3.06	5.28	8.32	3.71	16.79	9.74	5.29	7.50	1.89	0.15	-4.57
Nectar Lifesc	35.33	0.56	0.46	8.65	0.22	3.13	6.25	0.29	0.22	1.50	0.59	2.83
Add More

Annual Ratios (%)

Choose from Peers

Kilitch Drug
Ind-Swift Labs
Albert David
Medico Remedies
Zim Laboratories

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Insights

Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 97.52% as compared to Nifty Smallcap 100 which gave a return of 48.06%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 97.52% return as compared to Nifty Pharma which gave investors 56.71% return over 3 year time period. (as of last trading session)

Wanbury Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 1,30,29,561 39.76 % -0.01
Pledge 99,98,304 76.74 % 0.00
FII 2,75,372 0.84 % -0.18
DII 66 0.00 % 0.00
MF 66 0.00 % 0.00
Others 1,94,65,499 59.40 % 0.19
QoQ Change
Category Dec 2024 Sep 2024 Jun 2024 Mar 2024
Promoters 39.76 39.77 39.79 39.79
Pledge 76.74 76.74 76.74 71.05
FII 0.84 1.02 0.22 0.18
DII 0.00 0.00 0.00 0.00
Mutual Funds 0.00 0.00 0.00 0.00
Others 59.40 59.20 59.99 60.03

Mutual Funds Ownership

No Data Available

Wanbury Ltd Top Searches

Corporate Actions

Recent
Board Meeting
Quarterly Results & Others
Feb 10, 2025
General Meeting
Book closure from Feb 14, 2025 to Feb 20, 2025
Jan 24, 2025
Board Meeting
Quarterly Results
Nov 05, 2024

Announced on	Meeting on
Feb 10, 2025	Feb 12, 2025
Quarterly Results & Others
Nov 05, 2024	Nov 13, 2024
Quarterly Results
Aug 06, 2024	Aug 12, 2024
Quarterly Results
May 07, 2024	May 16, 2024
Audited Results
Jan 12, 2024	Jan 24, 2024
Quarterly Results

Dividends
Announced on Ex-Date Dividend%
May 31, 2010 Jul 29, 2010 10%
Dec 31, 2008 Mar 12, 2009 5%
Jun 29, 2007 Sep 13, 2007 20%
Jun 28, 2006 Sep 07, 2006 15%
Jan 31, 2006 Feb 20, 2006 5%
Bonus
No Data Available
Splits
No Data Available
Rights
Announced on Ex-Date
Sep 02, 1994 -
Rights ratio: 1 share for every 1 held at a price of Rs 10.0

AGM/EGM Meetings

Announced on	Meeting on
Jan 24, 2025	Feb 20, 2025
Book closure from Feb 14, 2025 to Feb 20, 2025
Sep 17, 2024	Sep 27, 2024
A.G.M.
Oct 26, 2023	Nov 18, 2023
-
Sep 18, 2023	Sep 27, 2023
A.G.M.
Jul 20, 2023	Aug 21, 2023
-

About Wanbury

Wanbury Ltd., incorporated in the year 1988, is a Small Cap company (having a market cap of Rs 525.28 Crore) operating in Pharmaceuticals sector.

Wanbury Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives and Scrap for the year ending 31-Mar-2023.

For the quarter ended 31-12-2024, the company has reported a Consolidated Total Income of Rs 134.29 Crore, down 17.52 % from last quarter Total Income of Rs 162.82 Crore and down 8.14 % from last year same quarter Total Income of Rs 146.19 Crore. Company has reported net profit after tax of Rs 1.22 Crore in latest quarter.

The company’s top management includes Mr.K Chandran, Mr.Mohan Kumar Rayana, Ms.Anupama Vaidya, Mr.Pravin Dilip Pawar, Mr.Mridul Sumanlal Mehta, Mr.Vinod Verma, Mr.Jitendra J Gandhi. Company has V Parekh & Associates as its auditors. As on 31-12-2024, the company has a total of 3.28 Crore shares outstanding.

Wanbury Ltd Share Price Today is Rs. 174.21. On previous day, the Wanbury Ltd Share Price (NSE) closed at Rs. 171.44, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Dec, 2024, the promoter held 39.76% of the stake in Wanbury Ltd shares, out of which 76.74% was pledged. On the same date, foreign institutional investors' (FII) holdings of Wanbury Ltd stocks was 0.84% as compared to 1.02% in Sep 2024 with decrease of 0.18%. The domestic institutional investors (DII) holdings on 31st Dec, 2024 was 0.0% as compared to 0.0% in Sep 2024 with decrease of 0.0%. Out of the total DII holdings in Wanbury Ltd shares 0.0% was held by mutual funds. The rest including public held is 59.4%. Wanbury Ltd stock price is reflected on both the exchanges - BSE and NSE.

Stock Forecast:
After showing 134.29 Cr. of sales and 17.52% of quarterly net loss, there have been multiple ups and downs in the Wanbury Ltd stock prices in the past few weeks. For example, Wanbury Ltd stock price on 24th of February 2025 was around Rs. 198.73. Wanbury Ltd share price now stands at an average of Rs. 174.21. Judging by last week's performance, stock is in down trend.

Wanbury Ltd has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Wanbury Ltd share.

Historical Prices and Performance:
Wanbury Ltd, incorporated in 1988 is a Small Cap company (with a market cap of Rs. 525.28) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Wanbury Ltd stock was 200.26%, 0.0%, -347.88%, 0.0% and -44.93% respectively.
The Wanbury Ltd share gave a 3 year return of 93.12% as compared to Nifty 50 which gave a return of 34.07%.
Wanbury Ltd announced 5.0% final dividend on February 20, 2006.

Key Metrics:
PE Ratio of Wanbury Ltd is 12.8
Prices/Sales Ratio of Wanbury Ltd is 0.83
Price/Book Ratio of Wanbury Ltd is 20.1

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Wanbury Ltd, major competitors and peers include Kopran Ltd, Anuh Pharma, Medicamen Bio and Nectar Lifesc. As of Sep 2024, the dividend yield of Wanbury Ltd stands at 0.0% while Kopran Ltd, Anuh Pharma, Medicamen Bio and Nectar Lifesc stand at 1.75%, 1.64%, 0.21% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 12.8 and 20.1 respectively.

Leadership of Wanbury Ltd :
Jitendra J Gandhi is Co. Secretary & Compl. Officer
Vinod Verma is Chief Financial Officer
K Chandran is Vice Chairman & Whole Time Dir
Anupama Vaidya is Ind. Non-Executive Woman Director
Mohan Kumar Rayana is Whole Time Director
Pravin Dilip Pawar is Ind. Non-Executive Director
Mridul Sumanlal Mehta is Addnl.Non Exe.Independent Director

Show More

Industry

Pharma - Indian

Key Indices Listed On

-

Address

BSEL Tech Park, B-Wing,10th Floor, Sector 30-A,Opp. Vashi Railway Station,New Mumbai, Maharashtra - 400703

Contact

http://www.wanbury.com

Executive Leadership

KC

K Chandran

Vice Chairman & Whole Time Dir

MK

Mohan Kumar Rayana

Whole Time Director

AV

Anupama Vaidya

Ind. Non-Executive Woman Director

PD

Pravin Dilip Pawar

Ind. Non-Executive Director

Show More

Auditors

Kapoor & Parekh Associates

V Parekh & Associates

FAQs about Wanbury share

1. What's the Wanbury Ltd share price today?
Wanbury Ltd share price is Rs 174.21 as of today. Wanbury Ltd share price is up by 8.69% based on previous share price of Rs. 240.65. In last 1 Month, Wanbury Ltd share price moved down by 19.32%.
2. What are the Wanbury Ltd quarterly results?
Total Revenue and Earning for Wanbury Ltd for the year ending 2024-03-31 was Rs 578.64 Cr and Rs 55.96 Cr on Consolidated basis. Last Quarter 2024-12-31, Wanbury Ltd reported an income of Rs 134.29 Cr and profit of Rs 1.22 Cr.
3. How can I quickly analyze Wanbury Ltd stock?
Key Metrics for Wanbury Ltd are:
- Price to Book ratio of Wanbury Ltd is 18.79
4. What dividend is Wanbury Ltd giving?
An equity Final dividend of Rs 1 per share was declared by Wanbury Ltd. on 31 May 2010. So, company has declared a dividend of 10% on face value of Rs 10 per share. The ex dividend date was 29 Jul 2010.
5. Who's the owner of Wanbury Ltd?
6. What are the returns for Wanbury Ltd share?
Return Performance of Wanbury Ltd Shares:
- 1 Week: Wanbury Ltd share price moved down by 7.83%
- 1 Month: Wanbury Ltd share price moved down by 19.32%
- 3 Month: Wanbury Ltd share price moved down by 34.51%
- 6 Month: Wanbury Ltd share price moved down by 26.77%
7. What is 52 week high/low of Wanbury Ltd share price?
In last 52 weeks Wanbury Ltd share had a high price of Rs 323.53 and low price of Rs 123.00
8. Who's the chairman of Wanbury Ltd?
K Chandran is the Vice Chairman & Whole Time Dir of Wanbury Ltd
9. What is the market cap of Wanbury Ltd?
Within the Pharmaceuticals sector, Wanbury Ltd stock has a market cap rank of 82. Wanbury Ltd has a market cap of Rs 580.99 Cr.
10. Who are the peers for Wanbury Ltd in Pharmaceuticals sector?
Within Pharmaceuticals sector Wanbury Ltd, Nectar Lifesciences Ltd., Kopran Ltd., Albert David Ltd., Medicamen Biotech Ltd., Medico Remedies Ltd., Ind-Swift Laboratories Ltd., Anuh Pharma Ltd., Zim Laboratories Ltd., Kilitch Drugs(I) Ltd. and Lyka Labs Ltd. are usually compared together by investors for analysis.

Top Gainers

As on 11:32 AM | 04 Mar 2025

Jyoti CNC Automation

866.50

95.75 (12.43%)

Vijaya Diagnostic

1,029.20

96.56 (10.36%)

279.60

23.06 (8.99%)

Concord Biotech Ltd.

1,643.70

122.30 (8.04%)

Alok Industries

16.05

1.17 (7.87%)

Top Losers

As on 11:26 AM | 04 Mar 2025

7,457.40

-257.41 (-3.34%)

112.97

-3.91 (-3.34%)

Astral Poly Tech

1,303.75

-44.60 (-3.31%)

Balkrishna Ind.

2,501.35

-81.16 (-3.15%)

4,694.00

-140.20 (-2.91%)

Equity Quick Links

Top Gainers
Top Losers
Stock Recommendations
Stock Screener
Candlestick Screener
Upcoming Dividends
Volume Shockers
Hourly losers
Hourly gainers

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.